Outcomes of surveillance versus adjuvant chemotherapy for patients with stage IA and IB nonseminomatous testicular germ cell tumors-Reference-Cited by-同舟云学术

Outcomes of surveillance versus adjuvant chemotherapy for patients with stage IA and IB nonseminomatous testicular germ cell tumors

Published:2016-11-03 Issue:7 Volume:35 Page:1103-1110
ISSN:0724-4983
Container-title:World Journal of Urology
language:en
Short-container-title:World J Urol

Author:

Gumus Mahmut,Bilici Ahmet,Odabas Hatice,Ustaalioglu Bala Basak Oven,Kandemir Nurten,Demirci Umut,Cihan Sener,Bayoglu Ibrahim Vedat,Ozturk Turkan,Turkmen Esma,Urakci Zurat,Seker Mehmet Metin,Gunaydin Yusuf,Selcukbiricik Fatih,Turan Nedim,Sevinc Alper

Publisher

Springer Science and Business Media LLC

Subject

Urology

Link

http://link.springer.com/article/10.1007/s00345-016-1964-6/fulltext.html

Reference27 articles.

1. Bhardwa JM, Powles T, Berney D, Baithun S, Nargund VH, Oliver RT (2005) Assessing the size and stage of testicular germ cell tumours: 1984–2003. BJU Int 96:819–821

2. Cohn-Cedermark G, Stahl O, Tandstad T (2015) Surveillance vs. adjuvant therapy of clinical stage I testicular tumors—a review and the SWENOTECA experience. Andrology 3:102–110

3. Vergouwe Y, Steyerberg EW, Eijkemans MJ, Albers P, Habbema JD (2003) External validity of a prediction rule for residual mass histology in testicular cancer: an evaluation for good prognosis patients. Br J Cancer 88:843–847

4. Klepp O, Olsson AM, Ous S, Nilsson S, Høisaether PA, Tveter K (1991) Early clinical stages of nonseminomatous testis cancer. Evaluation of the primary treatment and follow-up procedures of the SWENOTECA project. Scand J Urol Nephrol 25:179–190

5. Pont J, Albrecht W, Postner G, Sellner F, Angel K, Höltl W (1996) Adjuvant chemotherapy for high-risk clinical stage I nonseminomatous testicular germ cell cancer: long-term results of a prospective trial. J Clin Oncol 14:441–448

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Use of Risk Factors To Select Adjuvant Therapy Versus Surveillance for Testicular Nonseminoma and Seminoma Germ Cell Tumors;European Urology Focus;2024-05

2. Competing risk nomogram predicting cause-specific mortality in older patients with testicular germ cell tumors;Frontiers in Medicine;2024-04-17

3. Clinical characteristics and treatment outcomes of germ cell tumor in Jordan: A tertiary center experience;Arab Journal of Urology;2023-01-03

4. Single-course bleomycin, etoposide, and cisplatin (1xBEP) as adjuvant treatment in testicular nonseminoma clinical stage 1: outcome, safety, and risk factors for relapse in a population-based study;Therapeutic Advances in Medical Oncology;2022-01

5. PET imaging of testicular cancer;Nuclear Medicine and Molecular Imaging;2022